SPL

1.02%

9.7¢ starpharma holdings limited

Ann: DEP HER2-radiodiagnostic shows imaging benefits, page-24

First 24 Last

Share
Profile

Follow
Teddyward

9,400 Posts.

880

23/07/23

00:31

Post #: 68929110
Share

Originally posted by antibotter: ↑

Starpharma have been conducting multiple dep radiotheranostic pre clinical studies for at least 3 years now

Time to step up and take into human trials with a partner. Hopefully it will Roche/Genentech

Dr. Wabnitz has extensive experience in clinical development with a unique combination of clinical medicine, pharmacology, toxicology, and industry drug development experience. He has acted as an investigator and Medical Monitor on over 50 first in human Phase I/II clinical trials over the last two years, including several Phase I/II first in human oncology studies, as well as previously being the Executive Medical Director of a leading Australian Phase I clinical unit. His scientific background includes a Ph.D. in Organic Chemistry, a Post Doc at Parke-Davis (Ann Arbor, MI), 6.5 years of drug development industry experience (Pfizer/Esperion), an M.B.A. from the Stephen Ross School of Business (University of Ann Arbor, MI), and a Drug Development certificate in Regulatory Affairs from Temple University (Philadelphia, PA). His clinical background includes a Doctor of Medicine (M.D.), and he is a qualified Specialist Physician and Clinical Pharmacologist (Fellow of the Royal Australasian College of Physician, Australia).

Commenting on the significance of these findings, Clinical Pharmacology and Oncology specialist, Dr Paul Wabnitz, (MD, FRACP)3, said: “Translated clinically,

this technology has the potential to detect cancer cells at very low levels and better guide therapeutic decisions at earlier stages and at levels that were previously undetectable by current radiological methods.

This has several advantages, including dose optimisation and better identifying the minimal dose level for an efficacious response, thereby minimising toxicity and promoting the quality of life and care of cancer patients undergoing therapy.”

Expand

"Hopefully it will Roche/Genentech"

Astra are the elephant in this sector now and spending $ cornering parts of the market vertically - Why not them?

SPL Price at posting: 42.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

IMA

Issues emerging as Australian companies tackle critical minerals challenge

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

First 24 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.7¢		Change -0.001(1.02%)		Mkt cap ! $40.48M

Open	High	Low	Value	Volume
9.6¢	10.0¢	9.6¢	$5.703K	58.16K

Buyers (Bids)

No.	Vol.	Price($)
1	100000	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
9.8¢	20000	1

View Market Depth

No.	Vol.	Price($)
2	8325	0.095
3	160000	0.094
2	9659	0.093
2	134306	0.092
1	11000	0.091

Price($)	Vol.	No.
0.098	20000	1
0.100	4000	1
0.105	143620	3
0.110	198286	10
0.115	103400	3

Last trade - 15.41pm 11/10/2024 (20 minute delay)

SPL (ASX) Chart

Ann: DEP HER2-radiodiagnostic shows imaging benefits, page-24

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Issues emerging as Australian companies tackle critical minerals challenge

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Cauldron Energy reports "excellent" uranium assays in latest drill run

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: DEP HER2-radiodiagnostic shows imaging benefits, page-24

Top Stories

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Issues emerging as Australian companies tackle critical minerals challenge

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Cauldron Energy reports "excellent" uranium assays in latest drill run

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News